title: Lipids, curvature stress, and the action of lipid prodrugs: free fatty acids and lysolipid enhancement of drug transport across liposomal membranes.
abstract: Molecular shape and its impact on bilayer curvature stress are powerful concepts for describing the effects of lipids and fatty acids on fundamental membrane properties, such as passive permeability and derived properties like drug transport across liposomal membranes. We illustrate these relationships by studying the effects of fatty acids and lysolipids on the permeation of a potent anti-cancer drug, doxorubicin, across the bilayer of a liposome in which the drug is encapsulated. Using a simple fluorescence assay, we have systematically studied the passive permeation of doxorubicin across liposomal membranes in different lipid phases: the solid-ordered phase (DPPC bilayers), the liquid-disordered phase (POPC lipid bilayers), and the liquid-ordered phase induced by high levels of cholesterol (DOPC + cholesterol lipid bilayers). The effect of different free fatty acids (FA) and lysolipids (LL), separately and in combination, on permeability was assessed to elucidate the possible mechanism of phospholipase A(2)-triggered release in cancer tissue of liposomal doxorubicin formulations. In all cases, FAs applied separately lead to significant enhancement of permeability, most pronounced in liquid-disordered bilayers and less pronounced in solid and solid-ordered bilayers. LLs applied separately had only a marginal effect on permeability. FA and LL applied in combination lead to a synergistic enhancement of permeability in solid bilayers, whereas in liquid-disordered bilayers, the combined effect suppressed the otherwise strong permeability enhancement due to the FAs.
authors.affiliation: MEMPHYS-Center for Biomembrane Physics, Department of Physics and Chemistry, University of Southern Denmark, 55 Campusvej, DK-5230 Odense M, Denmark.
authors.forename: Henrik
authors.initials: H
authors.lastname: Jespersen
authors.forename: Jonas H
authors.initials: JH
authors.lastname: Andersen
authors.forename: Henrik J
authors.initials: HJ
authors.lastname: Ditzel
authors.forename: Ole G
authors.initials: OG
authors.lastname: Mouritsen
mesh_terms: D004317:Doxorubicin / Q000493:pharmacokinetics / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000737:chemistry*; D008055:Lipids / Q000737:chemistry* / Q000494:pharmacology; D008081:Liposomes; D008567:Membranes, Artificial; D011355:Prodrugs / Q000493:pharmacokinetics / Q000494:pharmacology*
chemical_list: D005230:Fatty Acids, Nonesterified; D008055:Lipids; D008081:Liposomes; D008567:Membranes, Artificial; D011355:Prodrugs; D004317:Doxorubicin